Literature DB >> 2684623

Effects of neuromedin B on insulin and glucagon release from the isolated perfused rat pancreas.

K Kawai1, H Mukai, Y Chiba, H Ohmori, S Suzuki, E Munekata, K Yamashita.   

Abstract

The effect of neuromedin B (NMB) on insulin and glucagon release was studied in isolated perfused rat pancreas. Infusion of NMB (10 nM, 100 nM and 1 microM) did not affect the insulin release under the perusate conditions of 5.5 mM glucose plus 10 mM arginine and 11 mM glucose plus 10 mM arginine, although 10 nM NMB tended to slightly suppress it under the perfusate condition of 5.5 mM glucose alone. The degree of stimulation of insulin release provoked by the addition of 5.5 mM glucose to the perfusate was not affected by the presence of 10 nM NMB. The glucagon release was slightly stimulated by the infusion of 100 nM and 1 microM NMB but not by 10 nM NMB under the perfusate condition of 5.5 mM glucose plus 10 mM arginine. The effect of C-terminal decapeptide of gastrin releasing peptide (GRP-10) was also examined and similar results were obtained; 10 nM and 100 nM GRP-10 did not affect insulin release and 100 nM GRP-10 stimulated glucagon release under the perfusate condition of 5.5 mM glucose plus 10 mM arginine. The present results concerning glucagon release are consistent with the previous results obtained with isolated perfused canine and porcine pancreas. However, the results regarding insulin release are not. Species differences in insulin release are also evident with other neuropeptides such as substance P and the mechanism of such differences remains for be clarified.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2684623     DOI: 10.1507/endocrj1954.36.587

Source DB:  PubMed          Journal:  Endocrinol Jpn        ISSN: 0013-7219


  1 in total

1.  Neuropeptide Neuromedin B does not alter body weight and glucose homeostasis nor does it act as an insulin-releasing peptide.

Authors:  Domagoj Cikes; Patricio Atanes; Shane J F Cronin; Astrid Hagelkrüys; Guo-Cai Huang; Shanta J Persaud; Josef M Penninger
Journal:  Sci Rep       Date:  2022-06-07       Impact factor: 4.996

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.